| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/18/2009 | EP1809267B1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 02/18/2009 | EP1727801B1 Piperazines useful for treating pain |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1392298B1 Fused heterocyclic compounds |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | CN101371142A Method of diagnosis and method of treatment |
| 02/18/2009 | CN101370517A Peptide derived from hepatitis C virus |
| 02/18/2009 | CN101370490A Compositions and methods for preventing or treating inflammatory bowel disease |
| 02/18/2009 | CN101368176A Complex phospho-esterase, extraction method and complex phospho-esterase capsule |
| 02/18/2009 | CN101368152A Preparation method for cordyceps sinensis solid haelth-care medicinal wine |
| 02/18/2009 | CN101368151A Wine additive, preparation and uses thereof |
| 02/18/2009 | CN101367883A Method for extracting glossy ganoderma polysaccharide from fermentation liquor |
| 02/18/2009 | CN101367869A Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
| 02/18/2009 | CN101367862A Method for quickly and massively separating high purity triptolide from thunder god vine |
| 02/18/2009 | CN101367859A Fatty acid bile acid couplet and medical uses thereof |
| 02/18/2009 | CN101367856A Methods and compositions for treating hepatitis c virus |
| 02/18/2009 | CN101367799A Matrine salviol acid B complex salt and kuh-seng native salviol acid B complex salt, preparation method and application thereof |
| 02/18/2009 | CN101366947A Method for inclusion of steroid medicament with hydrotalcite as carrier |
| 02/18/2009 | CN101366946A Starch based segmented intestine targeting specific adhesion material, preparation and application thereof |
| 02/18/2009 | CN101366938A Traditional Chinese medicine for treating gallstone |
| 02/18/2009 | CN101366937A Chinese medicine for treating colonitis |
| 02/18/2009 | CN101366932A Traditional Chinese medicine preparation for treating ulcerative colitis |
| 02/18/2009 | CN101366927A Honey gastrodia tuber plaster |
| 02/18/2009 | CN101366912A Oral liquid for children¡¯s foot and knee flaccidity |
| 02/18/2009 | CN101366900A Chinese medicine preparation for treating constipation |
| 02/18/2009 | CN101366897A Chinese medicine capsule for treating hepatitis B |
| 02/18/2009 | CN101366895A Cirrhosis and ascites treating plaster |
| 02/18/2009 | CN101366858A Preparation method of medicament for clearing heat, discharging fire, dispelling wind and relieving pain |
| 02/18/2009 | CN101366849A Quality control method for traditional Chinese medicine citrus aurantium |
| 02/18/2009 | CN101366827A Manchurian walnut bark extract and preparation method thereof |
| 02/18/2009 | CN101366826A Chinese medicinal herb for umbilicus for treating astroenteritis and special implementing instrument |
| 02/18/2009 | CN101366734A Synbiotics medicament composition |
| 02/18/2009 | CN101366733A Katsutoxin extract, preparation method and application thereof |
| 02/18/2009 | CN101366718A Uses of 7-hydroxide radical-star shaped spore native in preparing medicament for treating virus hepatitis |
| 02/18/2009 | CN101366711A Taurine and common oats fibre compound formulation, and uses thereof |
| 02/18/2009 | CN101366703A Omeprazole enteric coated pellets formulation and preparation method |
| 02/18/2009 | CN101366698A Biogastrone acid prosome liposome with long circulation function and preparation method thereof |
| 02/18/2009 | CN101366453A Non-antibiotic medicament for preventing and controlling pig lax |
| 02/18/2009 | CN101366423A Natural tea for protecting liver, relieving or neutralizing the effect of alcohol |
| 02/18/2009 | CN100462361C Formononetin-3'-sodium sulfonate, prunetin-3'-sodium sulfonate and their preparation process and medicinal use |
| 02/18/2009 | CN100462359C 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament |
| 02/18/2009 | CN100462351C Amino acids with affinity for the alpha-2-delta-protein |
| 02/18/2009 | CN100462104C Targeting-fusion DNA vaccine for caries-prevention, and its prepn. method |
| 02/18/2009 | CN100462072C Medicine composition used for injection and its preparing method |
| 02/18/2009 | CN100462068C Alphavbeta3 and alphavbeta6 integrin antagonists as antifibrotic agents |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491694 Dental restorative materials |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491406 Fast dissolving orally consumable films |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | US7491398 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 02/17/2009 | US7491386 lactic bacteria strain dairy in origin, may administer in an edible composition, adheres to tooth surface and produces growth inhibition factor |
| 02/17/2009 | CA2445189C Carboline derivatives as pdev inhibitors |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/17/2009 | CA2355283C Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/17/2009 | CA2348380C Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 02/17/2009 | CA2334267C Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 02/17/2009 | CA2316411C Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 02/12/2009 | WO2009019815A1 Novel γ-secretase inhibitor |
| 02/12/2009 | WO2009019571A2 Method of dissolving essential oils in water |
| 02/12/2009 | WO2009019473A1 Treatments for inflammatory arthritis |
| 02/12/2009 | WO2009019255A2 Synergetic composition comprising flavouring substances and organic acids and use thereof |
| 02/12/2009 | WO2008012089A8 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 02/12/2009 | US20090042988 Pharmaceutical compositions containing a meglitinide compound for preventing hepatic fibrosis |
| 02/12/2009 | US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042947 Pharmacologically active compounds containing sulfur |
| 02/12/2009 | US20090042931 Tricyclic Angiotensin II Agonists |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042873 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 02/12/2009 | US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042810 AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042771 Dietary lipids for improving skin and coat of pets |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041872 Encapsulated Vaccinium Extracts with Balanced Gastrointestinal Release |
| 02/12/2009 | US20090041788 Apo-2L receptor agonist and CPT-11 synergism |
| 02/12/2009 | US20090041784 Compositions and methods relating to glucagon receptor antibodies |
| 02/12/2009 | US20090041775 Use of CD25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 02/12/2009 | US20090041735 CD34 Stem cell-related methods and compositions |
| 02/12/2009 | US20090041726 Tumor therapy with high affinity laminin receptor-target vectors and combinations with chemotherapeutic agents |
| 02/12/2009 | CA2698752A1 Oral cannabinoid liquid formulations and methods of treatment |
| 02/12/2009 | CA2695877A1 Novel .gamma.-secretase inhibitor |
| 02/12/2009 | CA2695408A1 Synergetic composition comprising flavouring substances and organic acids and use thereof |
| 02/11/2009 | EP2022846A1 Method for isolation of stem cell |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2022500A1 Tumor suppressor |
| 02/11/2009 | EP2022494A2 Laxative preparation containing l-Arginine |
| 02/11/2009 | EP2021327A2 Antidiabetic bicyclic compounds |
| 02/11/2009 | EP2021025A1 Method and means for treating inflammatory bowel disease |
| 02/11/2009 | EP2020869A1 Hydroxybutyrate and poly-hydroxybutyrate as components of animal feed or feed additives |